311: Fauci's memoir, Alnylam's tenuous trial, and a mid-year review
The Readout Loud
00:00
Intro
The chapter covers the release of Anthony Fauci's memoir, updates on Alnylam's trial results and mid-year deal numbers in life sciences. Focus is given to an upcoming clinical trial for Alnylam's Vutryssiran, a drug targeting progressive heart disease, and its importance as their second attempt at developing a successful treatment for the condition.
Transcript
Play full episode
